Ultragenyx Pharmaceutical reported $159.87M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Biocryst Pharmaceuticals BCRX:US $ 417.48M 21.98M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Epizyme EPZM:US $ 71.07M 6.36M
Esperion Therapeutics ESPR:US $ 122.94M 27.42M
Insmed INSM:US $ 416.08M 99.63M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Kyowa Hakko Kirin 4151:JP Y 339886M 13414M
Macrogenics MGNX:US $ 21.47M 25.86M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Puma Biotechnology PBYI:US $ 52.76M 11.16M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
Vital Therapies VTL:US $ 88.08M 7.63M